The novel therapy of the medication represents a exciting breakthrough in the management of the condition. Distinct from existing medications, tirzepatide impacts dual pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – providing improved glucose regulation and potential weight reduction. Scientists are studying its potent